Clinical trial
Is Progression of Arteriosclerosis in ESRD Patients Inhibited by Nocturnal Hemodialysis or Renal Transplantation?
NCT00950573 is registered in ClinicalTrials.gov with Dianet Dialysis Centers as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Is Progression of Arteriosclerosis in ESRD Patients Inhibited by Nocturnal Hemodialysis or Renal Transplantation?
- Lead sponsor
- Dianet Dialysis Centers
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2010
- Completion date
- December 12, 2018
- Enrollment
- 184 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
kidney disease